GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
8.99
+0.11 (1.24%)
Jan 21, 2025, 4:00 PM EST - Market closed
GH Research Employees
GH Research had 49 employees as of December 31, 2023. The number of employees increased by 17 or 53.13% compared to the previous year.
Employees
49
Change (1Y)
17
Growth (1Y)
53.13%
Revenue / Employee
n/a
Profits / Employee
-$845,531
Market Cap
467.73M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49 | 17 | 53.13% |
Dec 31, 2022 | 32 | 18 | 128.57% |
Dec 31, 2021 | 14 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
GHRS News
- 11 days ago - GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents - GlobeNewsWire
- 2 months ago - GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - GlobeNewsWire
- 9 months ago - GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 11 months ago - GH Research Reports Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 1 year ago - GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression - GlobeNewsWire
- 1 year ago - GH Research Reports Third Quarter Financial Results and Provides Business Updates - GlobeNewsWire